JAZZ

Jazz Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality4/10
  • Growth↓ 0/10
  • Value↓ 1/10
Jazz Pharmaceuticals sales and earnings growth
JAZZ Growth
Low
  • Revenue Y/Y↑ 9.20%
  • EPS Y/Y↓ -93.97%
  • FCF Y/Y↓ -14.25%
Jazz Pharmaceuticals gross and profit margin trends
JAZZ Profitability
Good
  • Gross margin ↑ 88.00%
  • EPS margin↓ 0.70%
  • ROIC 5Y↓ 2.85%
Jazz Pharmaceuticals net debt vs free cash flow
JAZZ Risk
Good
  • Debt / Equity↓ 1.2
  • Debt / FCF↓ 2.7
  • Interest coverage↓ -0.2

Jazz Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

↗ More Biotechnology stocks